BiotechTube
Home/iBio/Martin Brenner
MB

Martin Brenner

Chief Executive Officer and Chief Scientific Officer

iBio

Therapeutic Areas

ObesityCardiometabolic Disease

iBio Pipeline

DrugIndicationPhase
IBIO-610Obesity and Cardiometabolic DiseaseIND-Enabling
Myostatin x Activin A BispecificObesity and Cardiometabolic DiseaseOptimization
IBIO-600Obesity and Cardiometabolic DiseaseIND-Enabling
Amylin AntibodyObesity and Cardiometabolic DiseaseOptimization
Target 4 ProgramObesity and Cardiometabolic DiseaseDiscovery

Leadership Team at iBio

FD
Felipe Duran
Chief Financial Officer
MB
Marc Banjak
Chief Legal Officer
CC
Chip Clark
Chairman of the Board
DA
David Arkowitz
Director
AK
Alexandra Kropotova
Director
AP
António Parada
Director
ES
Eef Schimmelpennink
Director
GS
Gary Sender
Director
View full iBio profile